Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk.
Ciro FranzeseStefano TomatisSofia Paola BianchiMarco PelizzoliMaria Ausilia TeriacaMarco BadalamentiTiziana ComitoElena ClericiDavide FranceschiniPierina NavarriaLuciana Di CristinaDamiano DeiCarmela GaldieriGiacomo ReggioriPietro MancosuMarta ScorsettiPublished in: Current oncology (Toronto, Ont.) (2023)
The adaptive strategy with re-planning is able to avoid an increase in dose to organs at risk and better target coverage in head-neck cancer patients, with potential benefits in terms of side effects and disease control.